AIM ImmunoTech Inc. — Form 8-K
Filed August 5, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 42/100
What the filing says
AIM ImmunoTech Inc. terminated a material definitive agreement effective July 31, 2026. The filing provides no specifics on the counterparty, dollar amounts, terms, or business impact of the termination. Without disclosure of what agreement was terminated or its significance to operations, the nature and consequence of this event cannot be determined from the filing text.
Why this rating
Material agreement termination is ordinarily significant, but zero disclosed details (counterparty, amount, business line, reason) prevent assessment of actual impact to a $6.4M company. Moderate uncertainty flag.
Extracted items
- 1.02 agreement termination
See more from August 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.